March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug development. The guidance, ...
A2LA-accredited Irvine lab explains why accredited vs. self-declared compliance determines COA acceptance by Amazon, ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
The FDA has released draft guidance aimed at helping drug developers shift away from traditional animal testing as the standard.
A rapid and simple method for testing the efficacy of antibacterial drugs on infectious microbes has been developed and validated by a team of Penn State researchers. Antimicrobial resistant infection ...
Methods and Guidance for Testing the Efficacy of Antimicrobials against Spores of Clostridium diffic
On September 29, 2017, the U.S. Environmental Protection Agency (EPA) announced the availability of two final test method Standard Operating Procedures (SOP) for evaluating the efficacy of ...
A new method seeks specific molecules that can target desired tissues through the bloodstream and penetrate tissues by passing through cells. This innovation could help solve issues related to drug ...
New cancer therapies are frequently evaluated in multiple disease indications. We evaluated whether the probability of achieving US Food and Drug Administration (FDA) approval for a new cancer therapy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results